J M Rimoldi,S S Chimote
J M Rimoldi
The scientific community has witnessed an exponential growth curve in the number of nitric oxide (NO) related publications over the last ten years. This diatomic radical is remarkably entangled (directly and indirectly) in a multitude of ph...
R M Jones,M G Paterlini
R M Jones
Recent advances in matrix metalloproteinase inhibitor research and development [0.03%]
Matrix金属蛋白酶抑制剂的研究进展与发展动向
M Whittaker,P Brown
M Whittaker
Protein kinase inhibitors: structural determinants for target specificity [0.03%]
蛋白激酶抑制剂：作用于靶点的结构决定因素
G McMahon,L Sun,C Liang et al.
G McMahon et al.
N Beeley,C Hill
N Beeley
Erratum [McMahon G, Sun L, Liang C, Tang C: Protein kinase inhibitors: structural determinants for target specificity. Current Opin Drug Discovery Dev (1998) 1(2):131-146. Correction to the structure of Compound 74 (SU-5874) in Figure 9] [0.03%]
勘误[麦克梅努、孙立、梁春等：蛋白激酶抑制剂：作用于特定目标的结构决定因子。《药物发现与开发》(1998)1(2):131-146.表9中化合物74（SU-5874）结构的更正]
R J Chambers
R J Chambers
Enantioselective acetylide additions: practical syntheses of non-nucleoside reverse transcriptase inhibitors [0.03%]
高选择性乙炔化添加法——非核苷类逆转录酶抑制剂的合成方法
R D Tillyer,E J Grabowski
R D Tillyer